Advances in therapeutic applications of silver nanoparticles
Copyright © 2023 Elsevier B.V. All rights reserved..
Nanotechnology is one of the most appealing area for developing new applications in biotechnology and medicine. For decades, nanoparticles have been extensively studied for a variety of biomedical applications. Silver has evolved into a potent antibacterial agent that can be used in a variety of nanostructured materials of various shapes and sizes. Silver nanoparticles (AgNP) based antimicrobial compounds are employed in a wide range of applications, including medicinal uses, surface treatment and coatings, the chemical and food industries, and agricultural productivity. When designing formulations for specific applications, the size, shape, and surface area of AgNPs are all crucial structural aspects to consider. Different methods for producing AgNPs with varying sizes and forms that are less harmful have been devised. The anticancer, anti-inflammatory, antibacterial, antiviral, and anti-angiogenic properties of AgNPs have been addressed in this review, as well as their generation and processes. Herein, we have reviewed the advances in therapeutic applications of AgNPs, as well as their limitations and barriers for future applications.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:382 |
|---|---|
| Enthalten in: |
Chemico-biological interactions - 382(2023) vom: 01. Sept., Seite 110590 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kaushal, Ashutosh [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 18.08.2023 Date Revised 18.08.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cbi.2023.110590 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM357702344 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM357702344 | ||
| 003 | DE-627 | ||
| 005 | 20231226073148.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cbi.2023.110590 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1192.xml |
| 035 | |a (DE-627)NLM357702344 | ||
| 035 | |a (NLM)37268200 | ||
| 035 | |a (PII)S0009-2797(23)00257-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kaushal, Ashutosh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Advances in therapeutic applications of silver nanoparticles |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.08.2023 | ||
| 500 | |a Date Revised 18.08.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier B.V. All rights reserved. | ||
| 520 | |a Nanotechnology is one of the most appealing area for developing new applications in biotechnology and medicine. For decades, nanoparticles have been extensively studied for a variety of biomedical applications. Silver has evolved into a potent antibacterial agent that can be used in a variety of nanostructured materials of various shapes and sizes. Silver nanoparticles (AgNP) based antimicrobial compounds are employed in a wide range of applications, including medicinal uses, surface treatment and coatings, the chemical and food industries, and agricultural productivity. When designing formulations for specific applications, the size, shape, and surface area of AgNPs are all crucial structural aspects to consider. Different methods for producing AgNPs with varying sizes and forms that are less harmful have been devised. The anticancer, anti-inflammatory, antibacterial, antiviral, and anti-angiogenic properties of AgNPs have been addressed in this review, as well as their generation and processes. Herein, we have reviewed the advances in therapeutic applications of AgNPs, as well as their limitations and barriers for future applications | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Antimicrobial effects | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Nanomaterials | |
| 650 | 4 | |a Oxidative stress | |
| 650 | 4 | |a Pharmacological effects | |
| 650 | 4 | |a Silver nanoparticles | |
| 650 | 7 | |a Silver |2 NLM | |
| 650 | 7 | |a 3M4G523W1G |2 NLM | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Adjuvants, Immunologic |2 NLM | |
| 650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
| 650 | 7 | |a Hypoglycemic Agents |2 NLM | |
| 700 | 1 | |a Khurana, Isha |e verfasserin |4 aut | |
| 700 | 1 | |a Yadav, Poonam |e verfasserin |4 aut | |
| 700 | 1 | |a Allawadhi, Prince |e verfasserin |4 aut | |
| 700 | 1 | |a Banothu, Anil Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Neeradi, Dinesh |e verfasserin |4 aut | |
| 700 | 1 | |a Thalugula, Sunitha |e verfasserin |4 aut | |
| 700 | 1 | |a Barani, Percy Jasmine |e verfasserin |4 aut | |
| 700 | 1 | |a Naik, Ramavath Redya |e verfasserin |4 aut | |
| 700 | 1 | |a Navik, Umashanker |e verfasserin |4 aut | |
| 700 | 1 | |a Bharani, Kala Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Khurana, Amit |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chemico-biological interactions |d 1969 |g 382(2023) vom: 01. Sept., Seite 110590 |w (DE-627)NLM000001848 |x 1872-7786 |7 nnns |
| 773 | 1 | 8 | |g volume:382 |g year:2023 |g day:01 |g month:09 |g pages:110590 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cbi.2023.110590 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 382 |j 2023 |b 01 |c 09 |h 110590 | ||